Boston Scientific Corp (NYSE:BSX) is among the best medical AI stocks to buy now. Piper Sandler reaffirmed its Overweight ...
MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary ...
Add Yahoo as a preferred source to see more of our stories on Google. Boston Scientific’s Watchman FLX Pro device, the latest version of its left atrial appendage closure system, was approved by the ...
Using anticoagulation alone—and avoiding aspirin— appears to limit adverse events after left atrial appendage occlusion (LAAO) with the Watchman FLX device (Boston Scientific), an analysis of ...
Boston Scientific Corp.’s OPTION study demonstrated left atrial appendage closure with the Watchman Flx device reduced risk of stroke compared to management with direct oral anticoagulants or warfarin ...
New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...
New data presented at the Cardiovascular Research Technologies (CRT) 2023 meeting reinforced the safety and effectiveness of Boston Scientific Corp.’s Watchman FLX left atrial appendage occlusion ...
Boston Scientific Corporation BSX shares are down on Monday as the company faces pressure following a significant clinical ...
Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart's upper chamber. It is a leading cause of stroke from clots that form in a small ...
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints PR Newswire ...
Atrial fibrillation (AF) is an increasingly common heart rhythm disorder that affects approximately 59 million people worldwide 1 and increases stroke risk by five times compared to people with a ...